SUFU Loss‐of‐Function Heterozygous Variants Cause a Distinct Neurodevelopmental Delay With Simultaneous Effects on Brain Size
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/1965385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 24.03.2026. Verfasst von Ludovico Graziani und 13 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Lazio.
Abstract (Originalsprache)
Heterozygous loss‐of‐function variants in SUFU are associated with Gorlin syndrome (MIM:620343) and tumor predisposition, while biallelic missense variants underlie recessive Joubert syndrome (JS; MIM:617757). Interestingly, emerging evidence suggests that SUFU haploinsufficiency also contributes to neurodevelopmental disorders (NDDs). We investigated 5 unrelated families encompassing 4 singletons and 1 pair of monozygotic twins carrying heterozygous SUFU loss‐of‐function variants through clinical, neuropsychological, and neuroimaging assessments and compared their features with 47 published cases fulfilling NDDs inclusion criteria. A consistent neurodevelopmental phenotype was observed, characterized by global developmental delay, hypotonia, congenital ocular motor apraxia, macrocephaly, and mild cerebellar abnormalities, including vermian hypoplasia and posterior fossa anomalies, variably falling within the JS spectrum. Craniofacial features were variably observed in our cohort and are reported as supportive clinical observations. Intellectual disability was present in ~35% of affected individuals, while autism spectrum disorder and behavioral difficulties occurred less frequently. Notably, neoplastic manifestations were absent among our cases, indicating that oncological and neurodevelopmental outcomes may segregate independently. SUFU haploinsufficiency may underlie a distinct dominantly inherited neurodevelopmental syndrome spanning from isolated ocular motor apraxia to a mild Joubert‐like phenotype with macrocephaly and variable cognitive/behavioral outcomes. These findings further refine the clinical description of the SUFU ‐related neurodevelopmental phenotype beyond tumor predisposition and support its inclusion in diagnostic panels for developmental delay, macrocephaly, and JS‐spectrum disorders. Multidisciplinary surveillance, balancing neurodevelopmental and oncological aspects, is recommended.
Förderung
- Regione Lazio
Zitieren
APA
Graziani, L., Minotti, C., Carriero, M. L., Travaglini, L., Nizon, M., Esch, H. V., Vogt, J., Drinkall, N., Jarvis, J., Agolini, E., Bengala, M., Mussa, A., Novelli, A., & Novelli, G. (2026). SUFU Loss‐of‐Function Heterozygous Variants Cause a Distinct Neurodevelopmental Delay With Simultaneous Effects on Brain Size. Human Mutation, 2026(1). https://doi.org/10.1155/humu/1965385
Vancouver
Graziani L, Minotti C, Carriero ML, Travaglini L, Nizon M, Esch HV, et al. SUFU Loss‐of‐Function Heterozygous Variants Cause a Distinct Neurodevelopmental Delay With Simultaneous Effects on Brain Size. Human Mutation. 2026;2026(1). doi:10.1155/humu/1965385
BibTeX
@article{Graziani2026,
author = {Graziani, Ludovico and Minotti, Chiara and Carriero, Miriam Lucia and Travaglini, Lorena and Nizon, Mathilde and Esch, Hilde Van and Vogt, Julie and Drinkall, Nick and Jarvis, Joanna and Agolini, Emanuele and Bengala, Mario and Mussa, Alessandro and Novelli, Antonio and Novelli, Giuseppe},
title = {SUFU Loss‐of‐Function Heterozygous Variants Cause a Distinct Neurodevelopmental Delay With Simultaneous Effects on Brain Size},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/1965385}
}
EUVIMED